BEONE MEDICINES LTD. Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- BEONE MEDICINES LTD. shares issued, value, share-based payment arrangement, after forfeiture for the quarter ending 2026-06-30 was $11.03M, a 66.30% decline year-over-year.
- BEONE MEDICINES LTD. shares issued, value, share-based payment arrangement, after forfeiture for the quarter ending 2026-03-31 was $23.83M, a 62.69% decline year-over-year.
- BEONE MEDICINES LTD. shares issued, value, share-based payment arrangement, after forfeiture for the quarter ending 2025-06-30 was $32.73M.
- BEONE MEDICINES LTD. shares issued, value, share-based payment arrangement, after forfeiture for the quarter ending 2025-03-31 was $63.88M.
- BEONE MEDICINES LTD. shares issued, value, share-based payment arrangement, after forfeiture for fiscal 2025 was $195.90M, a 330.05% increase from fiscal 2024.
- BEONE MEDICINES LTD. shares issued, value, share-based payment arrangement, after forfeiture for fiscal 2024 was $45.55M, a 14.06% decline from fiscal 2023.
- BEONE MEDICINES LTD. shares issued, value, share-based payment arrangement, after forfeiture for fiscal 2023 was $53.01M, a 12.87% increase from fiscal 2022.
- BEONE MEDICINES LTD. shares issued, value, share-based payment arrangement, after forfeiture for fiscal 2022 was $46.96M.
| Period end | Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture 3 month | Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture 12 month |
|---|---|---|
| 2026-06-30 | $11.03M 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $23.83M 10-Q · filed 2026-08-05 | |
| 2025-12-31 | $195.90M 10-K · filed 2026-02-26 | |
| 2025-06-30 | $32.73M 10-Q · filed 2026-08-05 | |
| 2025-03-31 | $63.88M 10-Q · filed 2026-08-05 | |
| 2024-12-31 | $45.55M 10-K · filed 2026-02-26 | |
| 2023-12-31 | $53.01M 10-K · filed 2026-02-26 | |
| 2022-12-31 | $46.96M 10-K · filed 2025-02-27 | |
| 2020-09-30 | $50.30M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $45.47M 10-Q · filed 2020-11-05 | |
| 2020-03-31 | $38.26M 10-Q · filed 2020-11-05 | |
| 2019-12-31 | $134.15M 10-K · filed 2020-03-02 | |
| 2019-09-30 | $36.82M 10-Q · filed 2020-11-05 | $121.77M derived: sum of 4 quarters · filed 2020-11-05 |
| 2019-06-30 | $32.60M 10-Q · filed 2020-11-05 | $110.08M derived: sum of 4 quarters · filed 2020-11-05 |
| 2019-03-31 | $26.39M 10-Q · filed 2020-11-05 | $96.12M derived: sum of 4 quarters · filed 2020-11-05 |
| 2018-12-31 | $25.96M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $87.13M 10-K · filed 2020-03-02 |
| 2018-09-30 | $25.13M 10-Q · filed 2019-11-12 | $77.63M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | $18.64M 10-Q · filed 2019-11-12 | $65.51M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-03-31 | $17.40M 10-Q · filed 2019-11-12 | |
| 2017-12-31 | $16.46M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $42.86M 10-K · filed 2020-03-02 |
| 2017-09-30 | $13.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | |
| 2016-12-31 | $10.70M 10-K · filed 2019-02-28 | |
| 2015-12-31 | $10.21M 10-K · filed 2018-02-28 | |
| 2014-12-31 | $4.80M 10-K · filed 2017-03-22 |